myeloproliferative neoplasms (MPN)

Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes

Author(s):

Kuykendall AT, Tokumori FC, Komrokji RS

Primary Author:

Kuykendall AT

Journal Title:

Hematology/oncology clinics of North America

Original Publication Date:

Apr 2021

Myelodysplastic syndrome/Myeloproliferative neoplasms (MDS/MPNs) are molecularly complex, clinically heterogeneous diseases that exhibit proliferative and dysplastic features. Diagnostic criteria use clinical, pathologic, and genomic features to distinguish between disease entities, though considerable clinical and genetic overlap persists. MDS/MPNs are associated with a poor prognosis, save for MDS/MPN with ring sideroblasts and thrombocytosis, which can behave more indolently.

Bone Marrow Diseases:

Transplant Virtual Support Group

Event Date:

Wed, 06/16/2021 - 5:00pm (EDT)

AAMDSIF is pleased to announce that we will host a support group for patients who have been treated with a transplant, or who are considering having a transplant. The group is hosted by AAMDSIF and will be monitored to ensure the privacy and safety of our participants.

Bone Marrow Diseases:

Young Adult Virtual Support Group

Event Date:

Tue, 06/29/2021 - 6:00pm (EDT)

This virtual support group is to help support patients between the ages of 18-30 who have been diagnosed with

Bone Marrow Diseases:

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

This phase I trial finds the best dose and side effects of venetoclax in combination with cladribine, cytarabine,

Joshua Zeidner, MD

Zeidner, Joshua

Dr. Zeidner's research interests include discovering innovative methods to improve outcomes, drug discovery and development, and designing clinical trials in

Online Profile:

https://unclineberger.org/directory/joshua-zeidner/

Daniel Weisdorf, MD

Weisdorf, Daniel

Hematologist/Oncologist

Masonic Cancer Center, University of Minnesota

Dr. Weisdorf's clinical and research interests are in application of blood and marrow transplant therapies for hematologic malignancies and extensive study of the clinical complications of transplantation including opportunistic infections and graft-versus-host disease.

Online Profile:

https://www.mhealth.org/providers/weisdorfdaniel-1546575118

Katherine Tarlock, MD

Tarlock, Katherine

Assistant Professor

Seattle Children's Hospital

Katherine Tarlock, M.D., is a board certified physician at Seattle Children’s Hospital and a UW assistant professor of pediatrics.

Dr. Tarlock believes the privilege of caring for patients and families during challenging medical diagnoses is what drew her to this field and continues to be the best part of her job. She is dedicated to advancing our understanding of leukemia and being able to offer every child and family the best care.

Dr. Tarlock earned her M.D. at Chicago Medical School. She is board certified in both Pediatrics and Pediatric Hematology/Oncology.

Online Profile:

https://www.seattlechildrens.org/directory/katherine-g-tarlock/